Q4 2024 Results Earnings Conference Call February 12, 2025 4:30 PM ETCompany ParticipantsElizabeth Chwalk - Senior Director ...
Welcome to AppLovin's earnings call for the fourth quarter and year ended December 31st, 2024. I'm David Hsiao, head o ...
Anthos Therapeutics is a clinical-stage biopharmaceutical company developing abelacimab, a potential first-in-class monoclonal antibody targeting the FXI inhibition pathwayAbelacimab is currently in P ...
The eruption of neo-Nazism and White Supremacy across the country has exposed the public to symbols, terms, and ideology drawn directly from Nazi Germany and Holocaust-era fascist movements. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results